Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Proleukin
Active Ingredient: Aldesleukin 18MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers: Chiron BV, Amsterdam, The Netherlands
Chiron Corporation, Emeryville, California, United States of America
Note: This consent is valid for two years from 27 January 2007.
Product: Proleukin
Active Ingredient: Aldesleukin 9MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers: Chiron BV, Amsterdam, The Netherlands
Chiron Corporation, Emeryville, California, United States of America
Note: This consent is valid for two years from 27 January 2007.
Product: Zevalin
Active Ingredient: Ibritumomab tiuxetan 1.6mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Baxter Pharmaceutical Solutions LLC, Bloomington, Indiana, United States of America
Note: This consent is valid for two years from 10 March 2007.
Dated this 9th day of March 2007.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).